Jan CPI Surprise Lows to 2.4% Sparks Fed Cut Outlook, Drives Tech and Biotech Stocks Higher

January CPI rose 0.2% month-over-month, down from 0.3% in December, with the annual rate easing to 2.4%. This cooled inflation supports expectations the Federal Reserve may begin cutting interest rates as early as June 2026, sending Treasuries higher and提振ing equities. Among impacted stocks: Amphastar Pharmaceuticals (NASDAQ: AMPS) gained 8.2% YTD despite a Neutral rating and a $30 price target from Bank of America after guidance for iron sucrose and glucagon sales was revised down, moderating growth from double-digits to high-single to low-double digits. AMPS closed at $28.63, 11.3% below its 52-week high of $32.29 as of February 13, 2026.